12 Health Care Stocks Moving In Thursday's Pre-Market Session
I'm LongbridgeAI, I can summarize articles.In Thursday's pre-market session, healthcare stocks showed mixed movements. VolitionRX surged 102.2% to $0.69, while NewcelX rose 15.08%. Other gainers included Ascentage Pharma, Catheter Precision, BioAtla, and Pomdoctor. Conversely, DataMEDS AI dropped 14.9%, followed by declines in Alaunos Therapeutics, Basel Medical Group, AC Immune, Clinuvel Pharmaceuticals, and ALPS Group.
Gainers
- VolitionRX (AMEX:VNRX) shares increased by 102.2% to $0.69 during Thursday's pre-market session. The company's market cap stands at $4.8 million.
- NewcelX (NASDAQ:NCEL) shares increased by 15.08% to $3.89. The company's market cap stands at $19.5 million.
- Ascentage Pharma Group (NASDAQ:AAPG) stock rose 10.59% to $18.69. The market value of their outstanding shares is at $1.5 billion.
- Catheter Precision (AMEX:VTAK) stock increased by 10.19% to $0.23.
- BioAtla (NASDAQ:BCAB) stock increased by 9.29% to $3.41. The market value of their outstanding shares is at $5.1 million.
- Pomdoctor (NASDAQ:POM) stock rose 8.42% to $1.03. The market value of their outstanding shares is at $113.2 million.
Losers
- DataMEDS AI (NASDAQ:MEDS) shares decreased by 14.9% to $1.14 during Thursday's pre-market session. The market value of their outstanding shares is at $4.0 million.
- Alaunos Therapeutics (NASDAQ:TCRT) stock decreased by 14.42% to $1.52. The company's market cap stands at $4.5 million.
- Basel Medical Group (NASDAQ:BMGL) stock declined by 13.06% to $5.16. The market value of their outstanding shares is at $9.2 million.
- AC Immune (NASDAQ:ACIU) stock declined by 8.78% to $2.6. The market value of their outstanding shares is at $290.0 million.
- Clinuvel Pharmaceuticals (NASDAQ:CUVL) shares fell 8.43% to $7.0. The market value of their outstanding shares is at $385.4 million.
- ALPS Group (NASDAQ:ALPS) shares decreased by 8.29% to $0.39. The company's market cap stands at $69.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.